These results might be due to the heterogenous activation status of IGF-1R, Src, and AXL at basal levels; only one to two kinases among IGF-1R, Src, and AXL were activated in the NSCLC cell lines used in this study. This evidence concerns the gene SRC and non-small cell lung carcinoma.